Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lang

Showing results (291-300 of 437) with videos related to

Pageof 44
Sort By:
Heart (British Cardiac Society)|September 20, 2018
Toxicity of cancer therapy: what the cardiologist needs to know about angiogenesis inhibitorsStephen J H Dobbin, Alan C Cameron, Mark C Petrie, et al.
Immunotherapy|August 4, 2016
Use of LDH and autoimmune side effects to predict response to ipilimumab treatmentJ Dick, N Lang, A Slynko, et al.
JACC. Cardiooncology|November 16, 2023
Cardiotoxicity of BRAF/MEK Inhibitors: A Longitudinal Study Incorporating Contemporary Definitions and Risk ScoresClaire Glen, Sarah Adam, Kirsty McDowell, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 27, 2000
The patterns of expression of an apoptosis-related CK18 neoepitope, the bcl-2 proto-oncogene, and the Ki67 proliferation marker in normal, hyperplastic, and malignant endometriumH M Morsi, M P Leers, W Jäger, et al.
Heart and Vessels|March 12, 2011
Vasomotor and fibrinolytic responses to kinin receptor agonists in the atherosclerotic human lower limbNicholas L M Cruden, Ninian N Lang, Thomas J MacGillivray, et al.
JACC. Cardiooncology|May 2, 2022
Mechanistic and Clinical Overview Cardiovascular Toxicity of BRAF and MEK Inhibitors: <i>JACC: CardioOncology</i> State-of-the-Art ReviewClaire Glen, Yun Yi Tan, Ashita Waterston, et al.
Cancer Gene Therapy|September 27, 2008
Intravenous injection of siRNA directed against hypoxia-inducible factors prolongs survival in a Lewis lung carcinoma cancer modelF Kamlah, B G Eul, S Li, et al.
Intensive Care Medicine Experimental|June 17, 2020
Use of the CytoSorb adsorption device in MDMA intoxication: a first-in-man application and in vitro studyCorinna N Lang, Michaela J Sommer, Merja A Neukamm, et al.
BMJ Open|August 31, 2021
Pulmonary thromboembolism in hospitalised patients with COVID-19: a retrospective national study of patients managed in critical care and ward environments in ScotlandMichael McGettrick, Alexander MacLellan, Paul McCaughey, et al.
BMC Emergency Medicine|December 8, 2020
Lung ultrasound in the emergency department - a valuable tool in the management of patients presenting with respiratory symptoms during the SARS-CoV-2 pandemicBonaventura Schmid, Doreen Feuerstein, Corinna N Lang, et al.
Pageof 44

Showing results (291-300 of 437) with videos related to

Sort By:
Pageof 44
Heart (British Cardiac Society)|September 20, 2018
Toxicity of cancer therapy: what the cardiologist needs to know about angiogenesis inhibitorsStephen J H Dobbin, Alan C Cameron, Mark C Petrie, et al.
Immunotherapy|August 4, 2016
Use of LDH and autoimmune side effects to predict response to ipilimumab treatmentJ Dick, N Lang, A Slynko, et al.
JACC. Cardiooncology|November 16, 2023
Cardiotoxicity of BRAF/MEK Inhibitors: A Longitudinal Study Incorporating Contemporary Definitions and Risk ScoresClaire Glen, Sarah Adam, Kirsty McDowell, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 27, 2000
The patterns of expression of an apoptosis-related CK18 neoepitope, the bcl-2 proto-oncogene, and the Ki67 proliferation marker in normal, hyperplastic, and malignant endometriumH M Morsi, M P Leers, W Jäger, et al.
Heart and Vessels|March 12, 2011
Vasomotor and fibrinolytic responses to kinin receptor agonists in the atherosclerotic human lower limbNicholas L M Cruden, Ninian N Lang, Thomas J MacGillivray, et al.
JACC. Cardiooncology|May 2, 2022
Mechanistic and Clinical Overview Cardiovascular Toxicity of BRAF and MEK Inhibitors: <i>JACC: CardioOncology</i> State-of-the-Art ReviewClaire Glen, Yun Yi Tan, Ashita Waterston, et al.
Cancer Gene Therapy|September 27, 2008
Intravenous injection of siRNA directed against hypoxia-inducible factors prolongs survival in a Lewis lung carcinoma cancer modelF Kamlah, B G Eul, S Li, et al.
Intensive Care Medicine Experimental|June 17, 2020
Use of the CytoSorb adsorption device in MDMA intoxication: a first-in-man application and in vitro studyCorinna N Lang, Michaela J Sommer, Merja A Neukamm, et al.
BMJ Open|August 31, 2021
Pulmonary thromboembolism in hospitalised patients with COVID-19: a retrospective national study of patients managed in critical care and ward environments in ScotlandMichael McGettrick, Alexander MacLellan, Paul McCaughey, et al.
BMC Emergency Medicine|December 8, 2020
Lung ultrasound in the emergency department - a valuable tool in the management of patients presenting with respiratory symptoms during the SARS-CoV-2 pandemicBonaventura Schmid, Doreen Feuerstein, Corinna N Lang, et al.
Pageof 44